GGrantIndex
Sort

17,828 grants matching crispr

Dissection of SARM1-Induced Axon Degeneration and Cell Death

$566,796
Jeffrey D Milbrandt · Washington University · R01 · FY2024 · NS

Stanford Project 2

$566,735
Calvin J Kuo · University Of California, San Francisco · U54 · FY2019 · CA

Targeting T cell glutamine metabolism in severe asthma

$566,703
Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2024 · HL

Robust Control of the Stem Cell Niche

$566,644
Xiling Shen · Duke University · R35 · FY2020 · GM

Mechanisms of Motor Superperformance

$566,625
Juan M. Pascual · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS

Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes

$566,573
Joseph C Wu · Stanford University · R01 · FY2021 · HL

Studies of amplification in rhabdomyosarcoma

$566,564
Frederic Barr · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Project 2: Genes required for dendritic cell responses to pathogens and T cells

$566,542
Nir Hacohen · Harvard Medical School · U19 · FY2017 · AI

Adaptive and maladaptive repair after kidney injury

$566,334
Katalin Susztak · University Of Pennsylvania · R01 · FY2025 · DK

Precision targeting of bladder cancer using CRISPR

$566,310
Mats Ljungman · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Mode of Action Core

$566,244
Bruce Steven Klein · University Of Wisconsin-Madison · U19 · FY2020 · AI

Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence

$566,215
Sam Anthony Myers · La Jolla Institute For Immunology · R01 · FY2025 · CA

Enhancing the C. elegans animal resource through genome editing

$566,208
Ann E. Rougvie · University Of Minnesota · R24 · FY2018 · OD

Cis Regulatory Elements and Systemic Lupus Erythematosus

$566,178
Joseph E Craft · Yale University · R01 · FY2019 · AR

Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities

$566,139
Matthew J Sikora · University Of Colorado Denver · R01 · FY2024 · CA

Establishing and reversing the functional consequences of Titin truncation mutations

$566,102
John Travis Hinson · University Of Connecticut Sch Of Med/Dnt · R01 · FY2022 · HL

Genomic profiling mediating the protective effect of social reward on opioid craving

$565,862
Marco Venniro · University Of Maryland Baltimore · R01 · FY2024 · DA

A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system

$565,829
Charles M. Rice · Rockefeller University · R01 · FY2025 · AI

Nonviral delivery of CRISPR-Cas9 into hepatocytes combined with APAP selection for treatment of Familial Hypercholesterolemia

$565,787
Renee Nicole Cottle · Clemson University · R56 · FY2023 · HL

Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma

$565,730
J. Silvio Gutkind · University Of California, San Diego · R01 · FY2021 · CA

Epigenetic dysregulation in diabetic enteric neuropathy

$565,705
Tamas Ordog · Mayo Clinic Rochester · R01 · FY2022 · DK

Role of lateral habenula in methamphetamine TAAR1-mediated synaptic plasticity and aversion

$565,579
Susan L Ingram Osborn · University Of Colorado Denver · R01 · FY2023 · DA

An ensemble framework for regulatory variant prediction.

$565,544
Dongwon Lee · Boston Children'S Hospital · R01 · FY2024 · HG

Reovirus Neuropathogenesis

$565,478
Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI

Integration and functionality of retinal organoid transplants

$565,326
Magdalene J Seiler · University Of California-Irvine · R01 · FY2024 · EY